US Market Entry & Expansion
The US doesn't run on the playbook that works at home.
Your playbook works at home. The US buyer doesn't care. When a global company hit that wall, I rebuilt the motion for the ground it had to win on and ran it solo. First three months of selling: 37 deals, 19 in a single month. More than 250 US client organizations across about two years. Entry is not a slide deck. It is a few hundred decisions made in the right order, under pressure, with no room for the wrong one. The revenue followed.
Go-to-Market & Revenue Operations
The commercial engine, engineered to compound.
How an organization finds real demand, proves value to skeptical buyers, and turns clinical credibility into revenue that compounds instead of stalling. Pipeline, motion, and the operating cadence underneath it.
Distributed Teams, On the Ground
Field teams run as a single front, not scattered headcount.
Distributed teams across healthcare, sales, and tech, hired, structured, and coordinated into one operating front. In regulated, relationship-driven markets, coordination is the product.
Intelligence & Automation, Applied With Restraint
Automation where it removes real work, nowhere it does not.
Decision support and automation built into the operation only where they take work off people and tighten the loop. The point is a sharper operation, not a longer tool list.